IRIS - Res&Arch Institutional Research Information System - Research & Archive

CHIAPPALUPI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.136
AS - Asia 1.677
EU - Europa 1.592
SA - Sud America 334
AF - Africa 58
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.812
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.057
SG - Singapore 744
IT - Italia 605
BR - Brasile 271
CN - Cina 237
IE - Irlanda 206
HK - Hong Kong 200
RU - Federazione Russa 156
DE - Germania 112
VN - Vietnam 97
KR - Corea 90
FR - Francia 89
SE - Svezia 61
BD - Bangladesh 57
GB - Regno Unito 57
NL - Olanda 56
IN - India 49
FI - Finlandia 48
CA - Canada 40
RO - Romania 40
AT - Austria 32
UA - Ucraina 32
PH - Filippine 27
JP - Giappone 26
TR - Turchia 26
IQ - Iraq 25
MX - Messico 22
ZA - Sudafrica 21
PL - Polonia 19
ES - Italia 18
CO - Colombia 16
BE - Belgio 15
PK - Pakistan 14
AR - Argentina 13
CH - Svizzera 10
EC - Ecuador 10
SA - Arabia Saudita 10
UZ - Uzbekistan 9
AU - Australia 8
ID - Indonesia 8
MA - Marocco 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
IR - Iran 6
TN - Tunisia 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
IL - Israele 5
LB - Libano 5
MD - Moldavia 5
TW - Taiwan 5
VE - Venezuela 5
AL - Albania 4
EG - Egitto 4
JO - Giordania 4
KH - Cambogia 4
LT - Lituania 4
MY - Malesia 4
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
UY - Uruguay 3
BY - Bielorussia 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
KE - Kenya 2
KG - Kirghizistan 2
NI - Nicaragua 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
CV - Capo Verde 1
DJ - Gibuti 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
IS - Islanda 1
LV - Lettonia 1
ML - Mali 1
MR - Mauritania 1
MU - Mauritius 1
MW - Malawi 1
NG - Nigeria 1
NO - Norvegia 1
Totale 5.809
Salva come PNG Salva come JPEG
Città #
Singapore 576
Chandler 253
San Jose 233
Dublin 202
Perugia 196
Hong Kong 190
Ashburn 151
San Mateo 89
Santa Clara 86
Boardman 77
Moscow 67
The Dalles 62
Beijing 53
Los Angeles 53
Lauterbourg 51
Dearborn 44
Redmond 44
Medford 41
Altamura 40
Ann Arbor 40
Munich 40
Princeton 40
Wilmington 38
Seoul 36
Bucharest 34
New York 34
Ho Chi Minh City 30
Turin 29
Bologna 28
São Paulo 28
Vienna 28
Andover 26
Lawrence 23
Falls Church 19
Seongnam-si 19
Tokyo 18
Montreal 17
Orem 17
Hanoi 16
Piscataway 16
Brussels 15
Amsterdam 14
Johannesburg 14
Cebu City 13
Falkenstein 13
Milan 13
Norwalk 12
Phoenix 12
Helsinki 11
London 11
Nuremberg 11
Rome 11
Warsaw 11
Boston 10
Brooklyn 10
Council Bluffs 10
Dallas 10
Denver 10
Saint Petersburg 10
Turku 10
Baghdad 9
Parma 9
Redwood City 9
Atlanta 8
Brasília 8
Da Nang 8
Frankfurt am Main 8
Groningen 8
Houston 8
Istanbul 8
Jacksonville 8
Mumbai 8
Tijuana 8
Toronto 8
Chennai 7
Columbus 7
Hefei 7
Rio de Janeiro 7
San Francisco 7
Stockholm 7
Collazzone 6
Des Moines 6
Dhaka 6
Florence 6
Glasgow 6
Incheon 6
Shanghai 6
Tashkent 6
Trinity 6
Baku 5
Belo Horizonte 5
Dong Ket 5
Jakarta 5
Lahore 5
Lappeenranta 5
Naples 5
Ottawa 5
Paris 5
Riyadh 5
Salvador 5
Totale 3.581
Salva come PNG Salva come JPEG
Nome #
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 198
Histological muscle characterization in hypertrophied Marchigiana cattle breed 174
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 173
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 161
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 155
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 149
RAGE in the pathophysiology of skeletal muscle. 147
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 147
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 140
Equisetum arvense standardized extract hinders age-related sarcopenia 139
S100B protein regulates myoblast and macrophage functions in skeletal muscle regeneration 138
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 138
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 136
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 135
Natural products to counteract muscle atrophy 133
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 131
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 128
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 126
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 126
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 124
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 110
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 110
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 108
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 107
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 107
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 106
Transplantation of microencapsulated Sertoli cells: a new potential antiinflammatory approach to Duchenne muscular dystrophy (DMD). 105
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 104
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 104
The effects of microgravity on human skeletal muscle regeneration. 103
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 101
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 101
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy 99
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 99
Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness 98
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 97
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 95
Reductive stress in striated muscle cells 94
The receptor RAGE: a potential molecular target in cancer cachexia 93
S100 proteins in obesity: liaisons dangereuses 93
HEREGULIN-INDUCED UTROPHIN UPREGULATION PROMOTES RECOVERY OF MUSCLE HOMEOSTASIS IN MDX MICE TRANSPLANTED WITH MICROENAPSULATED SERTOLI CELLS 92
Transplantation of microencapsulated Sertoli cells in mdx mice reduces muscle inflammation and promotes muscle regeneration 90
RAGE expression in rhabdomyosarcoma cells modulates metastasis formation in vivo. 89
Transplantation of microencapsulated Sertoli cells in a mouse model of Duchenne muscular dystrophy (DMD) reduces inflammation and rescues muscle performance. 88
Sertoli cells induce utrophin expression in human DMD myotubes with different mutations and exert promyogenic and antifibrotic effects 87
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 76
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 74
Self-powered temperature sensors harnessing membrane potential of living cells 73
Intraperitoneal transplantation of microencapsulated Sertoli cells counteracts muscle inflammation and rescues muscle performance in mdx mice. 68
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives 68
Sertoli cells improve myogenic differentiation, reduce fibrogenic markers, and induce utrophin expression in human dmd myoblasts 66
The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissue 58
Preparation of Human Muscle Precursor Cells for the MyoGravity Project - Cell Culture in Experiment Units for Space Flight Purpose 57
Sertoli cells have promyogenic and antifibrotic effects, and induce utrophin expression in human DMD myotubes with different mutations in a heregulin β1/ErbB2/ERK1/2-dependent manner 51
Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy 13
RAGE Re-Expressed at Myofibre Level Drives Muscle Wasting in Cancer Conditions 5
Totale 5.987
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 0 0 0 0 0 7
2021/2022420 4 65 9 19 12 12 12 106 12 39 58 72
2022/2023717 43 128 5 64 60 77 1 34 269 2 27 7
2023/2024387 18 28 9 35 18 12 102 8 19 24 37 77
2024/20251.448 46 103 148 84 166 68 136 153 195 87 186 76
2025/20262.367 140 116 96 276 308 206 384 155 229 195 211 51
Totale 5.987